| Literature DB >> 29259381 |
Yoon Jin Choi1, Young Soo Park1, Nayoung Kim1, Yong Sung Kim2, Sun Min Lee1, Dong Ho Lee1, Hyun Chae Jung3.
Abstract
AIM: to evaluate gender differences in the aspect of ghrelin, nociception-related genes and psychological aspects and the quality of life (QoL) in Korean functional dyspepsia (FD) patients.Entities:
Keywords: Functional dyspepsia; Gender differences; Quality of life
Mesh:
Substances:
Year: 2017 PMID: 29259381 PMCID: PMC5725300 DOI: 10.3748/wjg.v23.i45.8053
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Characteristics of the subjects n (%)
| Age (mean ± SD, yr) | 54.9 ± 12.1 | 57.4 ± 12.1 | 52.9 ± 11.8 | 50.5 ± 11.3 | 49.6 ± 11.6 | 51.3 ± 11.1 | 0.010 | 0.084 | 0.536 |
| Male | 38 (43.7) | 38 (100) | 0 | 39 ( 37.5) | 39 (100) | 0 | 0.386 | - | - |
| BMI (mean ± SD, kg/m | 23.1 ± 2.9 | 22.4 ± 2.9 | 22.9 ± 3.30 | 22.4 ± 3.0 | 23.3 ± 2.7 | 21.9 ± 3.4 | 0.140 | 0.482 | 0.039 |
| 58 (66.7) | 23 (60.5) | 35 (71.4) | 60 (57.7) | 21 (53.8) | 39 (60.0) | 0.204 | 0.360 | 0.547 | |
| AG antrum | 33 (37.9) | 15 (39.5) | 18 (36.7) | 28 (26.9) | 9 (23.1) | 19 (29.2) | 0.104 | 0.794 | 0.493 |
| AG body | 13 (14.9) | 5 (13.2) | 8 (16.3) | 11 (10.6) | 4 (10.3) | 7 (10.8) | 0.365 | 0.681 | 0.999 |
| IM antrum/body | 22 (25.3) | 12 (31.6) | 10 (20.4) | 18 (17.3) | 6 (15.4) | 12 (18.5) | 0.177 | 0.234 | 0.688 |
| Smoking | 13 (14.9) | 10 (26.3) | 1 (2.0) | 24 (23.1) | 17 (43.6) | 2 (3.1) | < 0.001 | < 0.001 | < 0.001 |
| Alcohol | 20 (23.0) | 16 (42.1) | 4 (8.2) | 30 (28.8) | 21 (53.8) | 9 (13.8) | 0.342 | < 0.001 | < 0.001 |
| Gynecologic surgery | - | - | 13/43 (30.2) | - | - | 25/48 (52.1) | 0.171 | - | - |
| Subtype in FD | - | - | - | - | - | - | - | - | - |
| PDS | - | - | - | - | 9 (23.1) | 15 (23.1) | - | - | 0.408 |
| EPS | - | - | - | - | 6 (15.4) | 17 (26.2) | - | - | - |
| Mixed | - | - | - | - | 24 (61.5) | 33 (50.8) | - | - | - |
Between males and females;
Hysterectomy, salpingooophorectomy or cesarean section were included. Only some patients responded to this question. AG: Atrophic gastritis; BMI: Body mass index; EPS: Epigastric pain syndrome; mixed, postprandial distress syndrome and epigastric pain syndrome; FD: Functional dyspepsia; IM: Intestinal metaplasia; PDS: Postprandial distress syndrome; SD: Standard deviation; -: not available.
Expression of plasma ghrelin, gastric peproghrelin and nociception-related genes in the control and functional dyspepsia groups
| Plasma acyl ghrelin (fmol/mL, median [IQR]) | 14.1 (9.1-20.8) | 15.9 (9.2-33.7) | 12.2 (9.0-18.6) | 11.2 (6.6-16.8) | 10.4 (6.5-18.4) | 11.4 (6.8-16.5) | 0.018 | 0.204 | 0.388 |
| Plasma des-acyl ghrelin(fmol/mL, median [IQR]) | 67.9 (37.5-162.5) | 108 (31.8-212.9) | 65.4 (38.2-111.0) | 62.1 (32.2-110.6) | 58.5 (28.8-134.3) | 63.6 (32.2-108.0) | 0.297 | 0.389 | 0.913 |
| Ghrelin mRNA (median [IQR]) | 2.6 (0.7-4.9) | 2.1 (0.5-4.2) | 3.2 (1.0-6.1) | 1.7 (0.4-5.4) | 1.9 (0.4-9.0) | 1.5 (0.3-4.7) | 0.435 | 0.076 | 0.308 |
| NGF mRNA (median [IQR]) | 1.1 (0.7-1.7) | 1.2 (0.7-1.8) | 0.9 (0.5-1.6) | 1.6 (0.9-2.3) | 1.8 (1.1-2.7) | 1.4 (0.8-2.2) | 0.006 | 0.056 | 0.129 |
| GDNF mRNA (median [IQR]) | 1.0 (0.7-1.6) | 1.2 (0.8-1.5) | 0.9 (0.7-1.7) | 1.8 (1.0-2.9) | 1.6 (1.1-3.0) | 1.9 (0.9-2.9) | < 0.001 | 0.404 | 0.992 |
| TRPV1 mRNA (median [IQR]) | 1.0 (0.6-1.5) | 1.1 (0.8-1.6) | 0.9 (0.6-1.2) | 1.4 (0.9-2.3) | 1.4 (0.9-2.2) | 1.4 (0.8-2.3) | 0.006 | 0.102 | 0.584 |
Mann-Whitney test was used;
Male vs female. FD: Functional dyspepsia; GDNF: Glial cell-line derived neurotrophic factor; IQR: Interquartile range; NGF: Nerve growth factor; PDS: Postprandial distress syndrome; TRPV1: Transient receptor potential vanilloid receptor 1.
Expression of plasma ghrelin, gastric peproghrelin and nociception-related genes in different gender
| Plasma acylghrelin (fmol/mL, median [IQR]) | 15.9 (9.2-33.7) | 10.4 (6.5-18.4) | 0.017 | 12.2 (9.0-18.6) | 11.4 (6.8-16.5) | 0.348 |
| Plasma des-acylghrelin (fmol/mL, median [IQR]) | 108.0 (31.8-212.9) | 58.5 (28.9-134.3) | 0.302 | 65.4 (38.2-111.0) | 63.6 (32.2-108.0) | 0.844 |
| Ghrelin mRNA (median [IQR]) | 2.1 (0.5-4.2) | 1.9 (0.4-9.1) | 0.428 | 3.2 (1.0-6.1) | 1.5 (0.3-4.7) | 0.092 |
| NGF mRNA (median [IQR]) | 1.2 (0.7-1.8) | 1.8 (1.1-2.7) | 0.002 | 0.9 (0.5-1.6) | 1.4 (0.8-2.2) | 0.119 |
| GDNF mRNA (median [IQR]) | 1.2 (0.7-1.5) | 1.6 (1.1-3.0) | 0.003 | 0.9 (0.7-1.7) | 1.9 (0.9-2.9) | 0.018 |
| TRPV1 mRNA (median [IQR]) | 1.1 (0.8-1.6) | 1.4 (0.9-2.2) | 0.014 | 0.9 (0.6-1.2) | 1.4 (0.8-2.3) | 0.089 |
1 Mann-Whitney test was used. FD: Functional dyspepsia; GDNF: Glial cell-line derived neurotrophic factor; IQR: Interquartile range; NGF: Nerve growth factor; PDS: Postprandial distress syndrome; TRPV1: Transient receptor potential vanilloid receptor 1.
Dyspepsia symptoms, stool consistency and bowel movement between males and females
| Overall abdominal pain | 3.4 ± 0.1 | 3.1 ± 0.2 | 0.195 |
| Early satiation (mean ± SE) | 2.8 ± 0.5 | 2.5 ± 0.3 | 0.434 |
| Postprandial fullness (mean ± SE) | 3.2 ± 0.3 | 3.1 ± 0.2 | 0.221 |
| Epigastric burning/pain (mean ± SE) | 2.7 ± 0.2 | 3.5 ± 0.1 | 0.047 |
| Bloating (mean ± SE) | 2.6 ± 0.3 | 2.2 ± 0.2 | 0.339 |
| Nausea (mean ± SE) | 1.5 ± 0.3 | 1.8 ± 0.2 | 0.327 |
| Vomiting (mean ± SE) | 0.5 ± 0.2 | 0.6 ± 0.1 | 0.203 |
| BSFS (mean ± SE) | 4.8 ± 0.2 | 4.4 ± 0.2 | 0.103 |
| Number (per week) (mean ± SE) | 4.8 ± 0.3 | 4.5 ± 0.2 | 0.532 |
t-test was used;
Pain not restricted to the epigastric area. BSFS: Bristol stool form score (from 1 = very hard to 7= watery); FD: Functional dyspepsia.
HADS and WHOQOL-BREF scores in the control and functional dyspepsia groups according to gender
| HADS score | |||||||||
| Total | 11.0 ± 0.8 | 10.8 ± 1.2 | 11.2 ± 1.1 | 15.8 ± 1.2 | 13.2 ± 1.3 | 18.6 ± 2.1 | 0.001 | 0.780 | 0.029 |
| Anxiety | 5.1 ± 0.4 | 4.9 ± 0.6 | 5.3 ± 0.6 | 7.4 ± 0.7 | 6.0 ± 0.7 | 9.0 ± 1.3 | 0.005 | 0.587 | 0.036 |
| Depression | 5.9 ± 0.4 | 5.9 ± 0.7 | 5.9 ± 0.6 | 8.4 ± 0.6 | 7.2 ± 0.8 | 9.7 ± 1.0 | 0.001 | 0.984 | 0.047 |
| WHOQOL-BREF score | |||||||||
| Total | 59.5 ± 1.6 | 60.7 ± 2.7 | 58.0 ± 1.5 | 54.0 ± 1.9 | 57.5 ± 1.9 | 51.6 ± 2.1 | 0.027 | 0.417 | 0.074 |
| Overall quality of life and general health | 6.2 ± 0.2 | 6.6 ± 0.3 | 5.8 ± 0.3 | 5.9 ± 0.3 | 6.5 ± 0.3 | 5.4 ± 0.3 | 0.278 | 0.080 | 0.020 |
| Physical domain | 13.4 ± 0.4 | 13.6 ± 0.7 | 13.1 ± 0.4 | 12.6 ± 0.4 | 13.6 ± 0.5 | 11.6 ± 0.7 | 0.185 | 0.575 | 0.016 |
| Psychological domain | 12.8 ± 0.4 | 13.2 ± 0.7 | 12.4 ± 0.5 | 11.8 ± 0.4 | 12.4 ± 0.5 | 11.4 ± 0.7 | 0.092 | 0.410 | 0.278 |
| Social domain | 13.7 ± 0.4 | 14.0 ± 0.6 | 13.3 ± 0.4 | 12.1 ± 0.5 | 13.0 ± 0.5 | 11.5 ± 0.6 | 0.012 | 0.370 | 0.064 |
| Environment domain | 13.3 ± 0.5 | 13.3 ± 0.7 | 13.3 ± 0.6 | 11.6 ± 0.4 | 12.1 ± 0.5 | 11.7 ± 0.7 | 0.010 | 0.990 | 0.617 |
t-test was used;
Between males and females;
Higher score denotes more severe symptom;
Higher score denotes better quality of life. FD: Functional dyspepsia; HADS: Hospital anxiety and depression scale; WHOQOL-BREF: World health organization quality of life abbreviated version.
Figure 1HADS and WHOQOL-BREF scores of patients with functional dyspepsia according to gender. HADS: Hospital anxiety and depression scale; WHOQOL-BREF: World health organization quality of life abbreviated version; QOL, quality of life. “a” denotes statistical significance.
Figure 2Correlation between epigastric burning/pain score and HADS anxiety score according to gender. Spearman correlation was used.